A detailed history of State Of New Jersey Common Pension Fund D transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 6,682 shares of MDGL stock, worth $2.25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,682
Previous 7,754 13.83%
Holding current value
$2.25 Million
Previous $1.65 Million 25.29%
% of portfolio
0.01%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

SELL
$202.45 - $354.85 $217,026 - $380,399
-1,072 Reduced 13.83%
6,682 $2.06 Million
Q3 2024

Nov 04, 2024

SELL
$212.22 - $292.96 $74,913 - $103,414
-353 Reduced 4.35%
7,754 $1.65 Million
Q2 2024

Aug 07, 2024

SELL
$193.33 - $291.99 $750,313 - $1.13 Million
-3,881 Reduced 32.37%
8,107 $2.27 Million
Q1 2024

May 02, 2024

SELL
$171.37 - $283.23 $191,591 - $316,651
-1,118 Reduced 8.53%
11,988 $3.2 Million
Q4 2023

Feb 02, 2024

SELL
$120.4 - $237.13 $111,129 - $218,870
-923 Reduced 6.58%
13,106 $3.03 Million
Q3 2023

Nov 08, 2023

BUY
$146.04 - $225.78 $792,120 - $1.22 Million
5,424 Added 63.03%
14,029 $2.05 Million
Q2 2023

Aug 02, 2023

BUY
$203.88 - $312.0 $132,522 - $202,800
650 Added 8.17%
8,605 $1.99 Million
Q1 2023

Apr 26, 2023

BUY
$231.06 - $307.08 $1.84 Million - $2.44 Million
7,955 New
7,955 $1.93 Million
Q3 2021

Oct 27, 2021

SELL
$78.35 - $105.02 $1.46 Million - $1.96 Million
-18,627 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$97.2 - $137.59 $1.81 Million - $2.56 Million
18,627 New
18,627 $1.81 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.77B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.